A Novel Approach to Discriminate Subgroups in Multiple Sclerosis.
Farrokhi M, Saadatpour Z, Fadaee E, Saadatpour L, Rezaei A, Moeini P, Amani Beni A.
Farrokhi M, et al.
Iran J Allergy Asthma Immunol. 2016 Dec;15(6):536-546.
Iran J Allergy Asthma Immunol. 2016.
PMID: 28129686
Free article.
Serum levels of sCD4, sCD8, and sCD163 of patients with relapsing-remitting MS (RRMS, n=61), primary progressive MS (PRMS, n=31), secondary progressive MS (SPMS, n=31), clinical isolated syndrome (CIS, n=31) and neuromyelitis optica (NMO, n=31), and healthy controls (n=49) were m …
Serum levels of sCD4, sCD8, and sCD163 of patients with relapsing-remitting MS (RRMS, n=61), primary progressive MS (PRMS, n=31), secondary …